Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/1999
11/09/1999US5981487 Method of inhibiting smooth muscle cell proliferation
11/09/1999US5981480 Pantropic neurotrophic factors
11/09/1999US5981472 Methods for treating diseases
11/09/1999US5981284 Technique for acceleration of apoptotic cell death
11/09/1999US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/09/1999US5981275 Plasmid comprising heterologous genes linked to cytomegalo virus promoters and stably produces heterologous gene product; for delivery to cells
11/09/1999US5981262 Nucleotide sequence coding a mammalian tyrosine kinase; for study of signal transduction pathway; for treatment of allergies and asthma; antiinflammatory agents
11/09/1999US5981256 Recombinant stratum corneum chymotryptic enzyme (SCCE)
11/09/1999US5981247 Nucleotide sequence coding a modified viral polymerase; for diagnosing infection and monitoring disease over time; for screening possible enzyme inhibitors; viricides
11/09/1999US5981246 Nucleic acids encoding EPH-like receptor protein tyrosine kinases
11/09/1999US5981245 Polypeptide kinase coded by a nucleic acid sequence; antibody development; for modulating kinase receptor activation and detecting receptor ligands
11/09/1999US5981228 Mammalian ZPAs
11/09/1999US5981224 Bovine heat shock promoter and uses thereof
11/09/1999US5981222 Mammalian polynucleotide encoding protein factor; for disease prevention and treatment
11/09/1999US5981220 Nucleotide sequences coding protein associated with skin differentiation; diagnostic assays for detecting bone and skin disorders; treatment of osteoporosis, bone fractures
11/09/1999US5981219 Dna which codes for transport protein important in nitrogen metabolism; for plants that are richer in protein but have reduced content of carbohydrates and fats and thus increased nutritional and economic value; for herbicides
11/09/1999US5981218 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis and encoded polypeptides
11/09/1999US5981214 Amplifying and recovering mammalian gene product in cell culture; culturing continuous cell line, insertion of regulatory sequence, by recombination, into genome near target gene, transfer and expression of mammalian gene product
11/09/1999US5981211 Continuous production of cell product from animal tissues or geneticaly engineered cells by trapping cells in insoluble, cell compatible matrix; supplying nutrient medium; withdrawing waste; withdrawing prodduct
11/09/1999US5981205 Nuclear Dbf2- related (Ndr) kinases
11/09/1999US5981195 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors
11/09/1999US5981194 Determining or monitoring alzheimer's disease in patients suspected of having alzheimer's disease; measuring the concentration of protein marker in sample and compare it a control; monitoring therapies for alzheimer's disease
11/09/1999US5981172 Probe for viral untranslated region; detecting viral nucleic acids; deveolping vaccines and antibodies to use as diagnostic tool in detecting presence of virus
11/09/1999US5981165 Exogenous activation and expression of tyrosine hydroxylase in neural cells; culturing mammalian cells of central nervous system; treatment for parkinson's disease and other nervous system disorders
11/09/1999US5980910 Useful in coating polymeric medical materials to prevent colonization by coagulase-negative staphylococcal strains, in assays for the detection of such bacteria
11/09/1999US5980897 Treating mammals suffering from infections caused by gram-negative bacteria
11/09/1999US5980888 Keratinocytes attached to microcarriers for treatment of skin wounds
11/09/1999US5980887 Methods for enhancing angiogenesis with endothelial progenitor cells
11/09/1999US5980885 Growth factor-induced proliferation of neural precursor cells in vivo
11/09/1999CA2087976C Process for producing magnetically responsive polymer particles and application thereof
11/09/1999CA1340815C Hybridomas producing monoclonal antibodies to new mucin epitopes
11/08/1999CA2269148A1 Novel methods for the production of gelatin and full-length triple helical collagen recombinant cells
11/06/1999CA2270711A1 Improved production of isoprenoids
11/04/1999WO1999055917A1 Mixed cell diagnostic systems
11/04/1999WO1999055906A2 Gene screening methods and related assays
11/04/1999WO1999055894A1 Construction of retroviral producer cells from adenoviral and retroviral vectors
11/04/1999WO1999055892A1 Use of triplex structure dna sequences for transferring nucleotide sequences
11/04/1999WO1999055878A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase
11/04/1999WO1999055876A2 Polypeptide with immunogenic properties and with a protein with modified biological functions
11/04/1999WO1999055873A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999WO1999055870A2 Transcription and gene expression regulators
11/04/1999WO1999055867A1 Delayed rectifier potassium channel subunit
11/04/1999WO1999055866A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/04/1999WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999WO1999055860A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999WO1999055858A2 Human nucleic acid sequences obtained from pancreas tumor tissue
11/04/1999WO1999055853A1 Novel immortalized hepatic cell line originating in humans
11/04/1999WO1999055852A1 Apolipoprotein e transgenic animals and assay methods
11/04/1999WO1999055846A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use
11/04/1999WO1999055845A1 Cellular and animal models for diseases associated with altered mitochondrial function
11/04/1999WO1999055844A2 Methods for modulating differentiation
11/04/1999WO1999055843A2 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects
11/04/1999WO1999055841A2 Process for obtaining stem cells
11/04/1999WO1999055838A1 Compositions and methods for the characterization and transplantation of mammalian retinal stem cells
11/04/1999WO1999055837A2 Improvements in or relating to separation processes
11/04/1999WO1999055832A2 Nucleic acid encoding rate agouti related protein
11/04/1999WO1999055831A2 Adenoviral vectors for treating disease
11/04/1999WO1999055735A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055732A1 A novel g-protein coupled receptor
11/04/1999WO1999055730A2 Polyepitope carrier protein
11/04/1999WO1999055729A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES
11/04/1999WO1999055722A2 Endothelial cell culture
11/04/1999WO1999055369A1 Monoclonal antibodies with reduced immunogenicity
11/04/1999WO1999055360A1 Implantable system with drug-eluting cells for on-demand local drug delivery
11/04/1999WO1999055354A1 Fertility improving composition and application thereof
11/04/1999WO1999055343A1 Cnre binding factors and uses thereof
11/04/1999WO1999055132A2 Generation of packaging system for human recombinant adenoviral vectors
11/04/1999WO1999047648A3 Medium and method for viral propagation and growth
11/04/1999WO1999046381A3 Human fgf gene and gene expression products
11/04/1999WO1999046372A3 Ribozymes capable of inhibiting the expression of the ccr5 receptor
11/04/1999WO1999046285A3 Method of promoting production of living tissue equivalents
11/04/1999WO1999042477A8 Transporter protein for saccharide-coupled medicaments
11/04/1999WO1999037788A9 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/04/1999WO1999033981A3 Human signal peptide-containing proteins
11/04/1999WO1999019481A3 Mammalian genes involved in viral infection and tumor suppression
11/04/1999DE19820190A1 Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor Human nucleic acid sequences from pancreatic tumor
11/04/1999DE19818098A1 Implant with improved tissue integration
11/04/1999CA2329975A1 Process for obtaining stem cells
11/04/1999CA2329857A1 A human derived immortalized liver cell line
11/04/1999CA2327505A1 Monoclonal antibodies with reduced immunogenicity
11/04/1999CA2327444A1 Construction of retroviral producer cells from adenoviral and retroviral vectors
11/04/1999CA2327352A1 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
11/04/1999CA2327317A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999CA2327178A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999CA2327176A1 Methods for modulating differentiation
11/04/1999CA2326819A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/04/1999CA2326755A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999CA2326601A1 Ese genes and proteins
11/04/1999CA2326380A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use
11/04/1999CA2326378A1 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects
11/04/1999CA2326376A1 Polyepitope carrier protein
11/04/1999CA2326375A1 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999CA2326233A1 Delayed rectifier potassium channel subunit
11/04/1999CA2325869A1 A novel g-protein coupled receptor
11/04/1999CA2325823A1 Gene screening methods and related assays
11/04/1999CA2323759A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase
11/04/1999CA2323235A1 Adenoviral vectors for treating disease
11/04/1999CA2295105A1 Generation of packaging system for human recombinant adenoviral vectors